Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

Companies willing to invest shrewdly in the downturn will emerge from it stronger.

Gaining an edge in a market reset: Bain's annual Global M&A report looks at how turbulent times produce strategic winners and losers.